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Abstract
Background: It was our aim to systematically analyze pulmonary artery blood flow within different age-groups in
the general population using 4D flow cardiovascular magnetic resonance (CMR) in order to provide a context for
interpreting results of future studies (e.g., in pulmonary hypertension) using this technique.
Methods: An age-stratified sample (n = 126) of the population of the city of Freiburg, Germany, underwent
ECG-triggered and navigator-gated 4D flow CMR at 3 T of the pulmonary arteries and the thoracic aorta. Analysis
planes were placed in the main, left, and right pulmonary artery using dedicated software. Study participants were
divided into three groups (1:20–39; 2:40–59; and 3:60–80 years of age). Subsequently, pulmonary blood flow was
visualized, quantified and compared between groups.
Results: Time-to-peak of systolic antegrade flow was shorter, peak and average velocities and flow volumes were
lower in older subjects. At the end of systole, retrograde flow in the main pulmonary artery was observed in all but
one subject. Subsequently, a second antegrade flow peak occurred in diastole which was lower in older subjects.
Age was an independent predictor of hemodynamic change after adjustment for cardiovascular risk factors and
body-mass-index. During systole, abnormal vortices occurred in the main pulmonary artery in four male subjects.
Conclusions: Comprehensive analysis of pulmonary blood flow was feasible in all subjects. We were able to detect
an independent effect of ageing on pulmonary hemodynamics reflecting increased vessel stiffness and reduced
pulmonary circulation. Findings of this study may be helpful for discriminating physiological from pathological flow
in patients with pulmonary diseases in the future.
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Background
Pulmonary artery blood flow is strongly dependent on ad-
equate cardiac function and absence of systemic vascular
disease and pathological conditions of the lungs. Hence,
many pathologic conditions may lead to altered pulmon-
ary hemodynamics and elevation of pulmonary arterial
pressure [1]. Pulmonary hypertension (PH, i.e., the eleva-
tion of mean pulmonary arterial pressure ≥25 mmHg [2])
is a serious condition which requires accurate assessment
of intrapulmonary hemodynamics and pressure to identify
patients, who will benefit from treatment. Currently, the
diagnostic gold-standard for intra-pulmonary pressure
evaluation is right-heart catheterization, which is an inva-
sive procedure. Hence, transthoracic echocardiography
(TTE) is used as a non-invasive screening tool by asses-
sing cardiac function and estimating pulmonary arterial
pressure non-invasively [3]. Unfortunately, specificity of
TTE for the identification of patients with PH is limited
and [3], therefore, other non-invasive diagnostic tools are
under investigation. One promising technique is 4D flow
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cardiovascular magnetic resonance (CMR), which allows
time-resolved and three-dimensional assessment of
hemodynamic parameters in vivo [4] and has already been
applied to the pulmonary arteries: PH was reported to be
associated with a decrease of flow parameters such as peak
systolic velocity, peak flow, stroke volume [5], the increase
of pulmonary artery (PA) diameter [6] and stiffness [7],
early onset of retrograde flow in the main pulmonary ar-
tery (MPA) [8], and the occurrence of abnormal vortices
[9, 10]. These findings were made by examining PH pa-
tients and healthy volunteers [5, 7–9]. Normal pulmonary
flow characteristics have previously been described using
2D phase-contrast CMR and echocardiography and have
been compared with right heart catheterization indicating
a higher agreement of CMR than of echocardiography
regarding pulmonary flow and pressure estimation [11].
However, previous studies were limited in sample size
[5, 7–9, 11]. Furthermore, 2D flow CMR is of limited use
in a clinical setting because it does not allow retrospective
selection of regions of interest inside a 3D data volume to
perform post-hoc quantification of blood flow parameters.
Using 4D flow CMR, all measurements are performed
within one dataset with no need for several 2D acquisi-
tions with inherent differences in heartrate [12]. These ad-
vantages may allow a more comprehensive study of
hemodynamic change during the course of PH. However,
reference values derived from the general population are
needed to interpret results of future interventional studies.
Methods
Study population
We performed a cross-sectional observational study of
the population of the city of Freiburg, Germany. Our
cohort was established on the basis of data obtained
from the local residents’ registration office. We included
at least 20 subjects per decade (10 females and 10 males)
within the age of 20–80 years. Starting in October 2012,
3500 age-stratified and randomly selected residents of
Freiburg were contacted by mail, asked to participate in
our study, and provided with details on how to contact
the study team. 308 subjects responded to our mail and
were contacted by phone on the basis of first-come,
first-served. 147 had to be excluded because of reporting
CMR contraindications during the telephone interview,
too many participants in this group of age, or because
no suitable date could be realized. 161 subjects were fi-
nally scheduled for study CMR. In 23 subjects the CMR
protocol was not completed for technical reasons, 11 did
not appear on the appointed day, 11 aborted CMR examin-
ation early because of claustrophobia, and 5 were not suited
for CMR due to contraindications that were not evident at
the preceding telephone interview. Because of insufficient
response within the group of 20–29 year old males, the
study was advertised on the University Hospital Freiburg
intranet and men within this age-interval (n = 922) were in-
vited to participate. The first 16 subjects who contacted the
study team by email were consecutively included. One per-
son had to be excluded for technical difficulties during
CMR and one subject did not arrive on the appointed day.
Finally, datasets of 126 subjects were available for analysis.
Cardiovascular risk factors and demographics were de-
termined by interview on site and blood pressure was
measured at the left upper arm in a supine position after
5 min rest before and after CMR examination. Heart rate
was documented every 5 min during CMR blood flow
measurements. All participants underwent additional
transthoracic echocardiography (TTE) using a Toshiba
Artida system (4.8-2 MHz PST-30BT transducer; Toshiba
Medical Systems Corporation, Tokyo, Japan) based on the
recommendations and standards of the American Society
of Echocardiography [13] on the same day (=median) as
CMR. The study was approved by the ethics committee of
the University of Freiburg and written informed consent
was obtained from all participants.
4D flow CMR
All CMR examinations were conducted on a routine 3-
Tesla MR system (TIM Trio, Siemens Healthcare AG, Er-
langen, Germany), using a standard 12-element body coil.
4D flow CMR was used to obtain time-resolved and three-
dimensional blood flow parameters of the pulmonary arter-
ies and the thoracic aorta. All experiments used prospective
ECG-gating and navigator-gating to allow free breathing
[14]. Parameters of 4D flow CMR were: echo time/repeti-
tion time (TE/TR) =2.6/5.1 ms, flip angle =7°, temporal
resolution =20.4 ms, matrix size =320 × 240 × 58, band-
width =450Hz/pixel, spatial resolution =2.1 × 2.1 × 2.5 mm,
velocity sensitivity along all three directions =150 cm/s, and
parallel imaging (PEAK-GRAPPA) along the phase encod-
ing direction (y) with an acceleration factor of R = 5 (20 ref-
erence lines).
Data analysis
4D flow CMR datasets were analyzed using MEVISFlow
software (Fraunhofer MEVIS, Bremen, Germany) [15].
After corrections for eddy-currents and phase-wraps, the
vessel was segmented and three analysis planes were manu-
ally positioned perpendicular to the vessel lumen in the
main pulmonary artery (MPA), the left pulmonary artery
(LPA), and the right pulmonary artery (RPA). All planes
were located with a distance of 1 cm from the center of the
bifurcation of the PA in order to avoid interference by local
flow turbulences in this area. For the comparison of pul-
monary and aortic blood flow a fourth analysis plane was
positioned in the ascending aorta (AAo) at the level of the
lower edge of the left pulmonary artery (see Fig. 1). For
each analysis plane, a lumen contour surrounding the
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lumen was defined manually while the contour was adapted
automatically to all time points of the cardiac cycle [15].
Parameters of pulmonary blood flow
The following parameters were evaluated because they
were either regarded as parameters of vascular function
or have been used earlier as potential surrogates for ele-
vated pulmonary arterial pressure [5, 6, 9, 10]: 1) mini-
mum (CSAmin), maximum (CSAmax), average (CSAavg)
and change (CSAchange) of cross-sectional-area of the
lumen and the MPA/AAo ratio (CSAratio) as calculated
from CSAmin, 2) time to peak systolic (TTPsys) and peak
diastolic (TTPdia) antegrade flow and time to peak retro-
grade flow (TTPret) as measured from the beginning of
the acquisition (i.e., the QRS), 3) parameters of planar
blood-flow (i.e., peak (Vmax) and average (Vavg) velocities
in any direction, peak systolic (Qmax-sys) and diastolic
(Qmax-dia) flow, mean flow per cardiac cycle (Qmean),
fraction of retrograde flow (RF), and cardiac output
(CO). Additionally, flow was visualized in the MPA plane
and analyzed regarding the appearance of vortices (i.e.,
flow which is mostly rotating on an axis line) and the ex-
tent of retrograde flow, which were both associated with
increased pulmonary pressure in earlier studies [8–10].
To test correctness of 4D flow CMR measures, conserva-
tion of mass was tested by measuring mean flow per car-
diac cycle in the MPA (QMPA), LPA (QLPA), RPA (QRPA),
and the AAo (QAAo). Provided that 4D flow CMR mea-
surements are accurate, blood flow was expected to be the
same during one cardiac cycle at the right and the left out-
flow tract of the heart: QMPA =QLPA +QRPA =QAAo.
Statistical analysis
Data are presented as mean (±standard deviations) or
median (interquartile range) for continuous, absolute and
relative frequencies for categorical variables. Regression
analysis was performed to quantify correlations of flow be-
tween various blood vessels. Furthermore, patients were
categorized according to their age into three groups which
were used for comparisons of blood flow: group 1 (20–39),
group 2 (40–59), and group 3 (60–80 years of age). Depar-
tures from normality were detected with the Shapiro-Wilk
statistic. Homogeneity of variance was assessed using
Levene’s test. Differences between patient groups were eval-
uated using Fisher’s exact test and one-way ANOVA with
Tukey’s HSD post-hoc test, respectively. Furthermore,
trends between groups were tested using linear regression
and correlations between age and hemodynamic parame-
ters were assessed after adjustment for cardiovascular risk
factors and body-mass-index. All tests were two-sided with
0.05 as the level of statistical significance. Statistical analyses
were performed using IBM-SPSS Statistics version 19.0.1.
Results
Patient characteristics
Cardiovascular risk factors, patient demographics and re-
sults from TTE are presented in Table 1. All participants
were caucasian. Hypertension and hypercholesterolemia
occurred more often in older subjects (group 3 > 2 > 1)
while no differences between groups were observed re-
garding the remaining risk factors. Only few subjects had
diabetes (n = 2), prior stroke (n = 2), coronary-artery-
disease (n = 2), and none of the subjects suffered from per-
ipheral vascular disease. In the onsite interview none of
Fig. 1 Positioning of analysis planes. a Analysis planes in the MPA, LPA, and RPA were positioned with a distance of 1 cm distal to the MPA
bifurcation. b The AAo plane was located in a standardized fashion on a level with the lower edge of the RPA. c 4D flow quantification was
performed in all four analysis planes
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the subjects reported a history of relevant lung disease
(i.e., asthma, chronic obstructive pulmonary disease, inter-
stitial lung disease, pulmonary embolism, tumor, pleural
disease or acute infection of the respiratory tract) at the
time of examination. In 54 (42.56 %) patients systolic PA
pressure could be quantified from tricuspid regurgitation
Doppler. Right ventricular systolic pressure was higher in
older patients (group 3 > 2 > 1) but still within the refer-
ence range according to the ASE recommendations [13]
and none of the patients had signs of PH. Echocardio-
graphic findings were within the reference range in all but
two individuals, with one having a mildly abnormal left-
ventricular function (EF =45 %) and one having an en-
larged left atrium (LA diameter =49 mm).
Conservation of mass during 4D flow quantification
Mean stroke volume of all subjects during one cardiac cycle
was 75.5 ± 17.2 ml in the MPA, a total of 74.1 ± 17.5 ml in
the LPA (34.0 ± 8.8 ml) plus RPA (40.1 ± 9.6 ml), and 74.3
± 18.2 ml in the ascending aorta (F(2375) = 0.24, p = 0.788).
Correlations were high between flow values in the
MPA and RPA + LPA (r = 0.92; p < 0.001), the MPA
and the AAo (r = 0.88; p < 0.001), and the RPA + LPA
and the AAo (r = 0.91; p < 0.001).
Age related change of flow
The mean cross-sectional area (CSA) of the pulmonary
arteries and the ascending aorta is given in Table 2. We
observed a trend that the CSA of the MPA was smaller
in older subjects, while the CSA of the AAo, LPA and
RPA was higher in older participants resulting in a pro-
portionally higher CSAratio in younger subjects (group
1 > 2 > 3; see Fig. 2). The CSAchange decreased with age
in the MPA and AAo as a marker of increased stiffness.
The flow profile in the MPA, LPA, and RPA compro-
mised three phases: 1) systolic antegrade flow, 2) end-
systolic and early-diastolic retrograde flow (in all but
one patient without any detectable retrograde flow), and
3) diastolic antegrade flow. The distribution of flow in
relation to the cardiac cycle is illustrated in Fig. 3 and
the position of landmarks (time-to-peak of antegrade
systolic, retrograde early-diastolic, and antegrade dia-
stolic flow) is given in Table 3. Peak systolic flow in the
MPA occurred later in the cardiac cycle in younger pa-
tients (group 1 > 2 + 3) while no difference was observed
regarding the time point of peak retrograde flow and
peak antegrade diastolic flow.
Systolic peak flow values (Qmax-sys) and corresponding
velocities (Vmax and Vavg) were higher in younger pa-
tients (group 1 > 2 > 3) (see Fig. 3 and Table 4) in the left
Table 1 Characteristics of study participants










Age, years(±SD) 30.07 (±5.4) 50.43 (±5.5) 68.95 (±5.2) <0.001*
Female, n(%) 19 (44.2) 24 (54.6) 21 (53.9) 0.564
Hypertension, n(%) 1 (2.3) 7 (16.3) 13 (33.3) <0.001*
Hypercholesterolemia, n(%) 1 (2.3) 9 (20.5) 11 (28.2) 0.005*
Diabetes, n(%) 0 (0.0) 1 (2.3) 1 (2.6) 0.587
Smoker, n(%) 11 (25.6) 6 (13.6) 5 (12.8) 0.223
BMI, 1(±SD) 24.02 (±4.0) 26.03 (±4.4) 24.31 (±3.8) 0.051
Prior stroke, n(%) 0 (0.0) 2 (4.6) 0 (0.0) 0.151
Coronary heart disease, n(%) 0 (0.0) 0 (0.0) 2 (5.1) 0.104
Peripheral arterial disease, n(%) 0 (0.0) 0 (0.0) 0 (0.0) –
Mean systolic BP, mmHg(±SD) 120.63 (±11.1) 126 (±15.7) 133.78 (±19.2) <0.001*
Mean diastolic BP, mmHg(±SD) 76.53 (±7.0) 81.88 (±8.3) 81.09 (±11.4) 0.014*
Heart rate, bpm(±SD) 67.16 (±7.9) 65.55 (±7.7) 66.1 (±9.1) 0.655
Ejection fraction, %(±SD) 56.6 (±20.7) 57.6 (±19.2) 53.6 (±22.5) 0.669
PI grade I, n(%) 3 (7.0) 1 (2.3) 1 (2.6) 0.246
PI grade II- IV, n(%) 0 (0.0) 0 (0.0) 0 (0.0) –
RVSP, mmHg(±SD) 15.82 (±2.4) 18.22 (±4.8) 22.05 (±5.7) <0.001*
TAPSE, mm(±SD) 22.93 (±4.1) 22.56 (±3.3) 23.06 (±3.7) 0.906
TDI, cm/s(%) 15.46 (±2.9) 15.53 (±1.8) 15.82 (±1.8) 0.592
Demographics, cardiovascular risk factors and results from transthoracic echocardiography of study participants. SD standard deviation, BP blood pressure, PI
pulmonary valve insufficiency, RVSP right ventricular systolic pressure, TAPSE tricuspid annular plane systolic excursion, TDI systolic velocity of the right ventricular
lateral annulus, *statistically significant
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and right pulmonary artery and the AAo. Also, the dia-
stolic peak flow volume was lower in older patients and
overall mean flow volume (Qmean) and, accordingly, car-
diac output as measured in the ascending aorta was
higher in younger participants (group 1 > 2 > 3). When
comparing hemodynamic parameters between the LPA
and the RPA intra-individually, it occurred that peak
(Vmax; p < 0.001) and average velocities (Vavg; p = 0.001),
peak (Qmax-sys; p = 0.003) and mean (Qmean; p < 0.001)
flow were higher in the RPA, while the fraction of retro-
grade flow was higher in the LPA (p < 0.001) (see
Table 4).
Age as an independent predictor of hemodynamic change
After adjustment for cardiovascular risk factors (i.e., ar-
terial hypertension and hypercholesterolemia) and body-
mass-index, age was found to be an independent
predictor of mean flow (Qmean-MPA (r = −0.22, p =
0.018), Qmean-LPA (r = −0.45, p < 0.001), Qmean-RPA (r =
−0.28, p = 0.002), Qmean-AAo (r = −0.37, p < 0.001)),
maximum flow (Qmax-LPA (r = −0.30, p = 0.001), Qmax-
RPA (r = −0.24, p = 0.008)), fraction of retrograde flow
(RFMPA (r = −0.22, p = 0.017), RFLPA (r = −0.26, p =
0.004)), cardiac output (r = −0.33, p < 0.001), mean vel-
ocities (Vmean-AAo (r = −0.47, p < 0.001), Vmean-LPA (r =
−0.48, p < 0.001), Vmean-RPA (r = −0.45, p < 0.001)),
maximum velocities (Vmax-AAo (r = −0.59, p < 0.001),
Vmax-LPA (r = −0.39, p < 0.001), Vmax-RPA (r = −0.32, p <
0.001)), minimum CSA (CSAmin-AAo (r = 0.35, p <
0.001)), maximum CSA (CSAmax-MPA (r = −0.25, p =
0.005), CSAmax-AAo (r = 0.28, p = 0.002)), mean CSA
(CSAmean-MPA (r = −0.22, p = 0.017), CSAmean-AAo (r =
0.32, p < 0.001)), MPA/AAo-CSA ratio (r = −0.50, p <
0.001) and CSAchange-AAo (r = −0.41, p < 0.001).
3D visualization of flow in the main pulmonary artery
We were able to visualize retrograde blood flow in the main
pulmonary artery in all but one participant. In all cases the
posterior wall of the MPA was affected by flow reversal.
The mean extent of retrograde flow was 0.9–1.4 cm
(F(2124) = 0.56; p = 0.574). During systole, abnormal vorti-
ces (Fig. 4 and Additional file 1: Supplemental video 1) oc-
curred in the MPA in four male subjects with the age of 20,
34, 37, and 60. These subjects had no history of PH and
showed no pathological findings in TTE examination.













MPA 6.53 ± 1.34 6.11 ± 1.21 5.78 ± 1.17 7.39 0.008*
LPA 3.31 ± 0.65 3.55 ± 1.23 3.69 ± 0.96 3.16 0.078
RPA 3.22 ± 0.62 3.59 ± 1.24 3.79 ± 1.07 6.35 0.013*
AAo 5.97 ± 1.35 7.05 ± 1.51 7.45 ± 1.48 21.41 <0.001*
CSAmin, cm
2(±SD)
MPA 5.19 ± 1.22 5.09 ± 0.96 4.82 ± 0.90 2.99 0.109
LPA 2.71 ± 0.62 2.93 ± 0.98 3.03 ± 0.85 3.08 0.082
RPA 2.46 ± 0.51 2.79 ± 0.99 2.95 ± 0.80 7.86 0.006*
AAo 5.08 ± 1.27 6.28 ± 1.39 6.77 ± 1.45 31.02 <0.001*
CSAavg, cm
2(±SD)
MPA 5.87 ± 1.27 5.61 ± 1.09 5.29 ± 1.03 5.23 0.024*
LPA 3.03 ± 0.62 3.24 ± 1.12 3.37 ± 0.91 2.59 0.088
RPA 2.88 ± 0.57 3.22 ± 1.13 3.39 ± 0.98 6.19 0.014*
AAo 5.59 ± 1.30 6.78 ± 1.46 7.19 ± 1.47 26.00 <0.001*
CSAratio, 1(±SD)
MPA/AAo 1.05 ± 0.23 0.83 ± 0.17 0.74 ± 0.19 51.56 <0.001*
CSAchange, %(±SD)
MPA 20.78 ± 5.30 16.35 ± 5.04 16.17 ± 5.03 17.06 <0.001*
LPA 18.56 ± 5.59 17.13 ± 3.55 18.29 ± 5.29 0.08 0.773
RPA 23.69 ± 5.52 22.23 ± 5.09 21.64 ± 6.01 2.85 0.094
AAo 15.06 ± 5.85 10.99 ± 4.09 9.26 ± 3.32 32.97 <0.001*
CSA cross-sectional-area, SD standard deviation, *statistically significant




Fig. 2 Cross-sectional area of the main pulmonary artery and ascending aorta. Scatter-plots indicating the positive association between diastolic
CSA in the ascending aorta and age (r = 0.47; p < 0.001), the lack of an significant association between the CSA of the main pulmonary artery and
age (r = 0.14; p = 0.11), and the negative association between the CSA ratio and age (r = −0.58; p < 0.001); the upper and lower line are indicating
the 95 % confidence interval of the trend line
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Discussion
In this study, we performed 4D flow CMR of the pul-
monary arteries in an age-stratified sample of 126 resi-
dents of Freiburg, a city in southern Germany with a
population of about 230,000. To our knowledge, this is
the first population-based study using 4D flow CMR to
systematically analyze pulmonary hemodynamics. The
purpose of our study was to provide reference values to
allow interpretation of findings in future studies using
4D flow CMR, which may both be used as a diagnostic
and screening tool if robust prediction of pulmonary
hypertension should be possible in the future. 4D flow
CMR measures proofed to be highly reliable for the
quantification of planar flow in the aorta along with high
Intra- and Inter-Observer agreement as shown previ-
ously [15]. Furthermore, 4D flow CMR flow measure-
ments have been validated in phantom studies using
predefined flow volumes and in comparison with estab-
lished standard sequences [16]. In our study, the
principle of conservation of mass showed excellent
agreement when comparing mean flow volumes at the
MPA, the combined LPA and RPA, and the AAo along
with high correlations. These results indicate that our
4D flow CMR protocol can be robustly used for measur-
ing hemodynamic parameters in the pulmonary arteries.
PA diameter is routinely used to identify PH, as PH is
associated with distended proximal pulmonary arteries
[17]. However, the definition of PA diameter cut-off
values remains problematic. Data from a previous study
which examined 51 PH patients (44.8 ± 15 years of age)
and 18 not age-matched normotensive controls (53.7 ±
17 years of age) demonstrated that the CSA of the pul-
monary arteries is significantly greater in relation to the
aortic CSA in PH patients [6]. Our study groups of 40–
59 and 60–80 year-old subjects had a similar mean
CSAratio of 0.83 ± 0.17 and 0.74 ± 0.19 when compared
with the CSAratio of 0.87 ± 0.17 in normotensive controls
in the study by Boerrigter et al. [6]. They suggested that
a dilated PA may be useful for identifying patients with
PH. In our study none of the older patients (≥40 years of
age) had a CSAratio ≥1. However, most of the younger
participants without evidence for existent PH had a
CSAratio ≥1, because the aortic CSA is usually smaller in
young subjects and therefore the ratio is higher. Our
data suggests that PA diameter remains relatively stable
over time, contrary to aortic diameter which increases
with age due to dilatative arteriopathy. Hence, changes
of the aortic CSA have to be taken into account when
identifying PH patients by an increase in CSAratio. This
may be reflected in the results of another study which
indicated that the ratio of PA to AAo diameter was no
predictor for mortality during a mean follow-up of 3
years [18]. Interestingly, we also detected an age
Fig. 3 Pulmonary artery flow profiles. The flow profile during the cardiac cycle is given for the main (MPA), the left (LPA), and the right (RPA)
pulmonary artery. Groups are represented by different colors (red: group 1 (age 20–39); orange: group 2 (age 40–59); blue: group 3 (age 60–80))












MPA 17.25 ± 3.58 15.31 ± 3.02 15.38 ± 3.20 6.70 0.011*
LPA 17.32 ± 6.29 14.65 ± 2.46 15.47 ± 2.50 3.97 0.049*
RPA 18.23 ± 3.52 16.24 ± 2.62 16.56 ± 7.92 2.20 0.140
AAo 15.06 ± 4.59 14.89 ± 5.48 13.46 ± 2.70 2.62 0.108
TTPret, %(±SD)
MPA 43.52 ± 7.45 43.16 ± 5.91 43.53 ± 4.63 0.00 0.994
LPA 45.26 ± 8.30 44.52 ± 8.29 50.97 ± 13.58 6.37 0.013*
RPA 46.69 ± 10.01 49.02 ± 13.89 49.97 ± 13.65 1.38 0.242
AAo 41.18 ± 9.614 39.51 ± 6.17 40.6 ± 4.33 1.40 0.709
TTPdia, %(±SD)
MPA 59.85 ± 9.296 59.37 ± 6.307 60.53 ± 8.112 0.15 0.701
LPA 61.06 ± 8.991 60.99 ± 7.276 66.76 ± 10.14 8.54 0.004*
RPA 61.72 ± 10.15 62.63 ± 9.908 63.11 ± 10.83 0.38 0.54
AAo 55.71 ± 10.03 57.76 ± 7.792 61.96 ± 9.991 9.26 0.003*
Time-to-peak (TTP) values in % of the cardiac cycle for peak antegrade systolic
(TTPsys) and diastolic (TTPdia), and early diastolic retrograde flow (TTPret). SD
standard deviation. *statistically significant
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dependent reduction of systolic to diastolic CSA change
during the heart cycle, which is a further parameter of
vascular stiffness and may be associated with increased
mortality in PH patients [17, 19].
Flow in the MPA, LPA, and RPA was triphasic with
antegrade flow in systole covering nearly 50 % of the
cardiac cycle, a regular short period of flow reversal, and
diastolic antegrade flow. Like in other large elastic arter-
ies, the elasticity of the pulmonary arteries contributes
to the Windkessel effect which has a reservoir function
by saving kinetic energy in systole and releasing it in
diastole. The Windkessel effect becomes diminished
with age as the pulmonary arteries loose compliance.
This results in a reduced elasticity and distensibility in
older subjects and explains that time-to-peak systolic
flow is shorter compared to younger participants. The
lower peak flow volume in older subjects on the other
hand can be explained by the age-related reduction of
(right-sided) cardiac function. In the absence of signifi-
cant pulmonary valve insufficiency, retrograde flow was
low in the pulmonary arteries and is mainly related to
valve closure. The recoil of the pulmonary arteries in












MPA 0.88 ± 0.17 0.88 ± 0.16 0.95 ± 0.29 1.86 0.175
LPA 0.85 ± 0.26 0.70 ± 0.16 0.65 ± 0.23 17.74 <0.001*
RPA 0.91 ± 0.18 0.79 ± 0.15 0.78 ± 0.23 9.22 0.003*
AAo 0.71 ± 0.16 0.58 ± 0.15 0.46 ± 0.14 55.34 <0.001*
Vavg, m/s(±SD)
MPA 0.23 ± 0.04 0.23 ± 0.04 0.23 ± 0.07 0.68 0.795
LPA 0.23 ± 0.05 0.19 ± 0.03 0.18 ± 0.05 27.40 <0.001*
RPA 0.25 ± 0.05 0.23 ± 0.03 0.21 ± 0.05 21.97 <0.001*
AAo 0.25 ± 0.05 0.23 ± 0.04 0.21 ± 0.05 22.25 <0.001*
Qmax-sys, mL(±SD)
MPA 354.2 ± 98.7 344.3 ± 92.6 328.8 ± 93.2 1.46 0.229
LPA 170.4 ± 50.3 150.4 ± 45.6 133.5 ± 56.9 10.73 <0.001*
RPA 186.4 ± 48.5 173.4 ± 44.6 157.3 ± 41.2 8.60 0.004*
AAo 398.5 ± 128.6 343.1 ± 113.6 327.1 ± 85.2 8.39 0.004*
Qmax-dia, mL(±SD)
MPA 52.1 ± 18.53 38.6 ± 15.62 29.4 ± 11.17 43.97 <0.001*
LPA 35.0 ± 11.83 22.2 ± 9.04 13.4 ± 8.5 96.55 <0.001*
RPA 28.1 ± 10.78 20.5 ± 9.71 17.1 ± 8.83 25.48 <0.001*
AAo 33.9 ± 14.46 29.5 ± 10.74 18.6 ± 8.07 36.26 <0.001*
Qmean, mL/cycle(±SD)
MPA 79.72 ± 19.41 74.89 ± 17.12 71.65 ± 13.87 4.59 0.034*
LPA 39.01 ± 8.11 33.35 ± 7.76 29.58 ± 8.04 28.04 <0.001*
RPA 43.07 ± 11.05 39.86 ± 8.68 37.04 ± 8.06 8.44 0.004*
AAo 82.21 ± 20.96 73.39 ± 15.64 66.48 ± 13.93 17.13 <0.001*
RF, %(±SD)
MPA 3.41 ± 2.74 2.09 ± 1.29 2.43 ± 1.76 4.75 0.031*
LPA 2.58 ± 1.65 1.48 ± 1.28 2.03 ± 2.13 2.16 0.144
RPA 1.49 ± 1.20 0.95 ± 0.79 1.66 ± 1.42 0.45 0.504
AAo 1.20 ± 1.12 1.34 ± 1.05 2.25 ± 2.77 7.08 0.009*
CO, L/min(±SD) 5.33 ± 1.56 4.77 ± 0.99 4.39 ± 1.08 11.90 <0.001*
Peak (Vmax) and mean (Vavg) velocities, peak systolic (Qmax-sys) and diastolic (Qmax-dia) antegrade flow volumes, mean flow volume per cardiac cycle (Qmean),
fraction of retrograde flow (RF), and cardiac output (CO) as measured in the AAo. SD standard deviation. *statistically significant
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diastole results in diastolic antegrade flow which, due to
the loss of elasticity, was diminished in older subjects.
Moreover, age-related reduction of cardiac function and
vascular elasticity explains that older subjects had lower
peak and mean velocities, peak systolic and diastolic ante-
grade flow values, and that mean flow volumes were lower
in the MPA, the LPA, and the RPA when compared to
younger patients. Barker et al. postulated that peak veloci-
ties, peak flow, and stroke volume were lower in PH pa-
tients compared to controls. We believe that part of this
result may be explained by the effect of ageing, because
controls (n = 19) were significantly younger than PH pa-
tients (n = 17) (39 vs. 57 years) in their study [5]. Further-
more, we observed that flow volumes and velocities were
higher in the RPA, which can simply be explained by the
inherent asymmetry of the lung and lung vascularization
with three lobes on the right and two on the left side.
Vortices in the MPA during systole have previously
been described to be sensitive and specific for the exist-
ence of PH [9]. This information is somewhat under-
lined by our findings with an absence of vortices of the
MPA in 97 % of our subjects. The occurrence of vortices
in the MPA in four participants without any pathological
findings in TTE may be explained by their individual
geometry of the pulmonary bifurcation, which enables
the formation of vortices in this area in absence of a
pathologic condition. Interestingly, vortices were only
detected in male subjects. However, given the low preva-
lence of vortices in only 3.2 % of all subjects and the
post-hoc nature of this finding, it requires an independ-
ent validation in a larger sample to substantiate a pos-
sible influence of geometry on vortex formation.
Potential limitations of our study were the amount of ini-
tial nonresponse to our study invitation. When compared
with registry data [20] and data from another German
population-based study [21] the subjects under investiga-
tion less often had hypertension, hypercholesterolemia, dia-
betes, were less often smokers, obese, and only few patients
suffered from a cardiovascular disease. This was probably
due to the recruitment modality which required partici-
pants to actively contact the study team and to visit the
University Medical Center. Accordingly, particularly health-
ier or health-conscious residents were probably interested
in collaborating in this study. Inclusion of sufficient number
of young (20–29 years of age) males is a common problem
in cohorts like ours. Accordingly, 14 included subjects were
recruited from the personnel of our institution (n = 922
male 20–29 years of age) on the basis of first come, first
serve to minimize bias. Furthermore, the presence of
comorbidity in the older age group may have influenced pa-
rameters of pulmonary flow. However, as we are interested
in the dependency on age at the population level with co-
morbidity as a part of the natural aging process and correla-
tions were adjusted for cardiovascular risk factors and
body-mass-index, we do not believe that this has an impact
on our results. Finally, due to the limited sample size we
were not able to address the question of potential sex differ-
ences in the different parameters systematically. However, a
potential confounding between the effects of age and sex
can be excluded due to including roughly the same propor-
tion of female subjects in each age group.
Conclusions
In conclusion, 4D flow CMR can be used to accurately
and comprehensively assess flow in the pulmonary arter-
ies in-vivo. Furthermore, we provided an overview of
hemodynamic changes which occur during life in the
general population independent from cardiovascular risk
(a) (b)
Fig. 4 Vortices in the main pulmonary artery. a A subject without appearance of vortices in the MPA. b A vortex (white arrow) appearing in the
MPA during systole
Wehrum et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:31 Page 8 of 9
factors and body-mass. This effect of ageing should be
taken into account when assessing pathologic conditions
in the pulmonary arteries in future studies using 4D flow
CMR to monitor effects of pulmonary hypertension.
Additional file
Additional file 1: Supplemental-video I. Occurrence of vortices in systole and
retrograde flow in the main pulmonary artery in a subject without cardiovas-
cular risk factors and no pathological findings in TTE. (MP4 2740 kb)
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